An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level

PLINK: a tool set for whole-genome association and population-based linkage analyses.

Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · see citing works

An integrated encyclopedia of DNA elements in the human genome

The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072 · see citing works

Systematic Localization of Common Disease-Associated Variation in Regulatory DNA

Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., et al. (2012) · Science · doi:10.1126/science.1222794 · Cited by 3,716 · see citing works

Mapping and analysis of chromatin state dynamics in nine human cell types

Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898 · see citing works

The accessible chromatin landscape of the human genome

Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679 · see citing works

Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test

Wu, M. C., Lee, S., Cai, T., Li, Y., Boehnke, M., & Lin, X. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.029 · Cited by 2,317 · see citing works

Genome editing with engineered zinc finger nucleases

Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285 · see citing works

A TALE nuclease architecture for efficient genome editing

Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098 · see citing works

Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting

Čermák, T., Doyle, E., Christian, M. L., Wang, L., Zhang, Y., Schmidt, C. L., Baller, J. A., Somia, N. V., Bogdanove, A. J., & Voytas, D. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr218 · Cited by 2,034 · see citing works

TALENs: A widely applicable technology for targeted genome editing

Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650 · see citing works

Human genetic variation and its contribution to complex traits

Frazer, K. A., Murray, S. S., Schork, N. J., & Topol, E. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2554 · Cited by 1,073 · see citing works

Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor <i>BCL11A</i>

Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919 · see citing works

Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay

Melnikov, A., Murugan, A., Zhang, X., Tesileanu, T., Wang, L., Rogov, P., Feizi, S., Gnirke, A., Callan, C. G., Kinney, J. B., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2137 · Cited by 711 · see citing works

Genome-wide association study shows <i>BCL11A</i> associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia

Uda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672 · see citing works

DNA polymorphisms at the BCL11A , HBS1L-MYB , and β- globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease

Lettre, G., Sankaran, V. G., Bezerra, M., Araujo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 560 · see citing works

Massively parallel functional dissection of mammalian enhancers in vivo

Patwardhan, R. P., Hiatt, J. B., Witten, D. M., Kim, M. J., Smith, R. P., May, D., Lee, C., Andrie, J. M., Lee, S.-I., Cooper, G. M., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2136 · Cited by 536 · see citing works

A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15

Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529 · see citing works

ATM stabilizes DNA double-strand-break complexes during V(D)J recombination

Bredemeyer, A. L., Sharma, G. G., Huang, C., Helmink, B. A., Walker, L. M., Khor, K. C., Nuskey, B., Sullivan, K. E., Pandita, T. K., Bassing, C. H., et al. (2006) · Nature · doi:10.1038/nature04866 · Cited by 425 · see citing works

Developmental and species-divergent globin switching are driven by BCL11A

Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., et al. (2009) · Nature · doi:10.1038/nature08243 · Cited by 379 · see citing works

Transcriptional silencing of γ-globin by BCL11A involves long-range interactions and cooperation with SOX6

Xu, J., Sankaran, V. G., Ni, M., Menne, T. F., Puram, R. V., Kim, W., & Orkin, S. H. (2010) · Genes &amp; Development · doi:10.1101/gad.1897310 · Cited by 361 · see citing works

Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart

He, A., Kong, S. W., Ma, Q., & Pu, W. T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016959108 · Cited by 360 · see citing works

Bcl11a is essential for normal lymphoid development

Liu, P., Keller, J. R., Ortiz, M., Tessarollo, L., Rachel, R. A., Nakamura, T., Jenkins, N. A., & Copeland, N. G. (2003) · Nature Immunology · doi:10.1038/ni925 · Cited by 351 · see citing works

Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing

Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., et al. (2011) · Science · doi:10.1126/science.1211053 · Cited by 326 · see citing works

Seventy-five genetic loci influencing the human red blood cell

van der Harst, P., Zhang, W., Leach, I. M., Rendon, A., Verweij, N., Sehmi, J., Paul, D. S., Elling, U., Allayee, H., Li, X., et al. (2012) · Nature · doi:10.1038/nature11677 · Cited by 306 · see citing works

Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation

Galarneau, G., Palmer, C. D., Sankaran, V. G., Orkin, S. H., Hirschhorn, J. N., & Lettre, G. (2010) · Nature Genetics · doi:10.1038/ng.707 · Cited by 267 · see citing works

Intragenic Enhancers Act as Alternative Promoters

Kowalczyk, M. S., Hughes, J. R., Garrick, D., Lynch, M. D., Sharpe, J. A., Sloane-Stanley, J. A., McGowan, S. J., De Gobbi, M., Hosseini, M., Vernimmen, D., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.021 · Cited by 267 · see citing works

Targeted chromosomal deletions in human cells using zinc finger nucleasesPreprint

Lee, H. J., Kim, E., & Kim, J. (2009) · Genome Research · doi:10.1101/gr.099747.109 · Cited by 250 · see citing works

The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation

Soler, E., Andrieu-Soler, C., de Boer, E., Bryne, J. C., Thongjuea, S., Stadhouders, R., Palstra, R.-J., Stevens, M., Kockx, C., van IJcken, W., et al. (2010) · Genes &amp; Development · doi:10.1101/gad.551810 · Cited by 245 · see citing works

Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A

Xu, J., Bauer, D. E., Kerenyi, M. A., Vo, T. D., Hou, S., Hsu, Y.-J., Yao, H., Trowbridge, J. J., Mandel, G., & Orkin, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303976110 · Cited by 233 · see citing works

Bcl11a is essential for lymphoid development and negatively regulates p53

Yu, Y., Wang, J., Khaled, W. T., Burke, S., Li, P., Chen, X., Yang, W., Jenkins, N. A., Copeland, N. G., Zhang, S., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121846 · Cited by 223 · see citing works

Combinatorial Assembly of Developmental Stage-Specific Enhancers Controls Gene Expression Programs during Human Erythropoiesis

Xu, J., Shao, Z., Glass, K., Bauer, D. E., Pinello, L., Handel, B. V., Hou, S., Stamatoyannopoulos, J. A., Mikkola, H. K. A., Yuan, G., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.09.003 · Cited by 196 · see citing works

A complex task? Direct modulation of transcription factors with small molecules

Koehler, A. N. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.022 · Cited by 189 · see citing works

A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E

Nuinoon, M., Makarasara, W., Mushiroda, T., Setianingsih, I., Wahidiyat, P. A., Sripichai, O., Kumasaka, N., Takahashi, A., Svasti, S., Munkongdee, T., et al. (2009) · Human Genetics · doi:10.1007/s00439-009-0770-2 · Cited by 185 · see citing works

Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders

Bauer, D. E., Kamran, S. C., & Orkin, S. H. (2012) · Blood · doi:10.1182/blood-2012-06-292078 · Cited by 177 · see citing works

Genome-wide identification of TAL1's functional targets: Insights into its mechanisms of action in primary erythroid cellsPreprint

Kassouf, M. T., Hughes, J. R., Taylor, S., McGowan, S. J., Soneji, S., Green, A. L., Vyas, P., & Porcher, C. (2010) · Genome Research · doi:10.1101/gr.104935.110 · Cited by 176 · see citing works

CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis

Leid, M., Ishmael, J. E., Avram, D., Shepherd, D., Fraulob, V., & Dollé, P. (2004) · Gene Expression Patterns · doi:10.1016/j.modgep.2004.03.009 · Cited by 156 · see citing works

A transient definitive erythroid lineage with unique regulation of the β-globin locus in the mammalian embryo

McGrath, K. E., Frame, J. M., Fromm, G. J., Koniski, A. D., Kingsley, P. D., Little, J. A., Bulger, M., & Palis, J. (2011) · Blood · doi:10.1182/blood-2010-12-325357 · Cited by 145 · see citing works

Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5′ olfactory receptor gene cluster

Solovieff, N., Milton, J. N., Hartley, S. W., Sherva, R., Paola Sebastiani, B., Dworkis, D. A., Klings, E. S., Farrer, L. A., Garrett, M. E., Ashley‐Koch, A. E., et al. (2009) · Blood · doi:10.1182/blood-2009-08-239517 · Cited by 141 · see citing works

Amelioration of Sardinian 0 thalassemia by genetic modifiers

Galanello, R., Sanna, S., Perseu, L., Sollaino, M. C., Satta, S., Lai, M. E., Barella, S., Uda, M., Usala, G., Abecasis, G. R., et al. (2009) · Blood · doi:10.1182/blood-2009-04-217901 · Cited by 136 · see citing works

The IgH Locus 3′ Regulatory Region

Pinaud, E., Marquet, M., Fiancette, R., Péron, S., Vincent‐Fabert, C., Denizot, Y., & Cogné, M. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387663-8.00002-8 · Cited by 134 · see citing works

The majority of the in vitro erythroid expansion potential resides in CD34- cells, outweighing the contribution of CD34+ cells and significantly increasing the erythroblast yield from peripheral blood samples

van den Akker, E., Satchwell, T. J., Pellegrin, S., Daniels, G. L., & Toye, A. M. (2010) · Haematologica · doi:10.3324/haematol.2009.019828 · Cited by 133 · see citing works

Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with Sickle Cell Disease1

FARBER, M., Koshy, M., KINNEY, T., & THECOOPERATIVESTUDYOFSICKLECE (1985) · Journal of Chronic Diseases · doi:10.1016/0021-9681(85)90033-5 · Cited by 122 · see citing works

An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice

McDevitt, M. A., Fujiwara, Y., Shivdasani, R. A., & Orkin, S. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7976 · Cited by 94 · see citing works

Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients

Bhatnagar, P., Purvis, S. H., Barron‐Casella, E. A., DeBaun, M. R., Casella, J. F., Arking, D. E., & Keefer, J. R. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.12 · Cited by 89 · see citing works

Joining the loops: β‐Globin gene regulation

Noordermeer, D., & de Laat, W. L. (2008) · IUBMB Life · doi:10.1002/iub.129 · Cited by 89 · see citing works

Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans

Bae, H. T., Baldwin, C. T., Paola Sebastiani, B., Telen, M. J., Ashley‐Koch, A. E., Garrett, M. E., Hooper, W. C., Bean, C. J., DeBaun, M. R., Arking, D. E., et al. (2012) · Blood · doi:10.1182/blood-2012-06-432849 · Cited by 84 · see citing works

Bcl11a is required for neuronal morphogenesis and sensory circuit formation in dorsal spinal cord development

John, A., Brylka, H., Wiegreffe, C., Simon, R., Liu, P., Jüttner, R., Crenshaw, E. B., Luyten, F. P., Jenkins, N. A., Copeland, N. G., et al. (2012) · Development · doi:10.1242/dev.072850 · Cited by 69 · see citing works

Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice

Esteghamat, F., Gillemans, N., Bilić, I., van den Akker, E., Cantú, I., van Gent, T., Klingmüller, U., van Lom, K., Lindern, M. V., Grosveld, F. G., et al. (2013) · Blood · doi:10.1182/blood-2012-06-434530 · Cited by 51 · see citing works

Maps of Open Chromatin Guide the Functional Follow-Up of Genome-Wide Association Signals: Application to Hematological Traits

Paul, D. S., Nisbet, J. P., Yang, T.-P., Meacham, S., Rendon, A., Hautaviita, K., Tallila, J., White, J. K., Tijssen, M. R., Sivapalaratnam, S., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002139 · Cited by 46 · see citing works

New Tool for Genome Surgery

John van der, O. O. S. T. (2013) · Science · doi:10.1126/science.1234726 · Cited by 44 · see citing works

Chapter 5 Long‐Range Regulation of α‐Globin Gene Expression

Higgs, D. R., Vernimmen, D., & Wood, B. (2008) · Advances in genetics · doi:10.1016/s0065-2660(07)00005-3 · Cited by 32 · see citing works

Genomewide Association Studies and Common Disease — Realizing Clinical Utility

Fugger, L. H., McVean, G., & Bell, J. I. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1212285 · Cited by 31 · see citing works

High-throughput haplotype determination over long distances by haplotype fusion PCR and ligation haplotyping

Turner, D. J., & Hurles, M. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.184 · Cited by 18 · see citing works

Determination of haplotypes at structurally complex regions using emulsion haplotype fusion PCR

Tyson, J., & Armour, J. A. L. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-693 · Cited by 5 · see citing works

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031054 · Cited by 1,962 · see citing works

Sickle cell disease

Piel, F. B., Steinberg, M. H., & Rees, D. C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510865 · Cited by 1,488 · see citing works

Therapeutic genome editing: prospects and challenges

Cox, D. B. T., Platt, R. J., & Zhang, F. (2015) · Nature Medicine · doi:10.1038/nm.3793 · Cited by 1,336 · see citing works

Gene therapy returns to centre stage

Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184 · see citing works

Long-range enhancer–promoter contacts in gene expression control

Schoenfelder, S., & Fraser, P. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0128-0 · Cited by 1,102 · see citing works

The selection and function of cell type-specific enhancers

Heinz, S., Romanoski, C. E., Benner, C., & Glass, C. K. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3949 · Cited by 1,010 · see citing works

BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis

Canver, M. C., Smith, E. C., Sher, F., Pinello, L., Sanjana, N. E., Shalem, O., Chen, D. D., Schupp, P. G., Vinjamur, D. S., Garcia, S. P., et al. (2015) · Nature · doi:10.1038/nature15521 · Cited by 886 · see citing works

The Post-GWAS Era: From Association to Function

Gallagher, M. D., & Chen-Plotkin, A. S. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.04.002 · Cited by 822 · see citing works

Beyond GWASs: Illuminating the Dark Road from Association to Function

Edwards, S. L., Beesley, J., French, J. D., & Dunning, A. M. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.012 · Cited by 784 · see citing works

Genome-editing Technologies for Gene and Cell Therapy

Maeder, M. L., & Gersbach, C. A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.10 · Cited by 722 · see citing works

Sickle Cell Disease.

Piel, F. B., Steinberg, M., & Rees, D. C. (2016) · Spiral (Imperial College London) · doi:10.1056/nejmc1706325#sa6 · Cited by 662 · see citing works

Non-coding genetic variants in human disease: Figure 1.

Zhang, F., & Lupski, J. R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv259 · Cited by 588 · see citing works

Identifying Causal Variants at Loci with Multiple Signals of Association

Hormozdiari, F., Kostem, E., Kang, E. Y., Pasaniuc, B., & Eskin, E. (2014) · Genetics · doi:10.1534/genetics.114.167908 · Cited by 465 · see citing works

Highly efficient therapeutic gene editing of human hematopoietic stem cells

Wu, Y., Zeng, J., Roscoe, B. P., Liu, P., Yao, Q., Lazzarotto, C. R., Clement, K., Cole, M. A., Luk, K., Baricordi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0401-y · Cited by 515 · see citing works

Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing

Amabile, A., Migliara, A., Capasso, P., Biffi, M., Cittaro, D., Naldini, L., & Lombardo, A. (2016) · Cell · doi:10.1016/j.cell.2016.09.006 · Cited by 516 · see citing works

Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9

Mandal, P. K., Ferreira, L. M. R., Collins, R., Meissner, T. B., Boutwell, C. L., Friesen, M., Vrbanac, V., Garrison, B. S., Stortchevoi, A., Bryder, D., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.10.004 · Cited by 475 · see citing works

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Frangoul, H., Locatelli, F., Sharma, A., Bhatia, M., Mapara, M., Molinari, L., Wall, D., Liem, R. I., Telfer, P., Shah, A. J., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2309676 · Cited by 493 · see citing works

Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch

Liu, N., Hargreaves, V. V., Zhu, Q., Kurland, J. V., Hong, J., Kim, W., Sher, F., Macias-Trevino, C., Rogers, J. M., Kurita, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.016 · Cited by 478 · see citing works

A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression

Gupta, R. M., Hadaya, J., Trehan, A., Zekavat, S. M., Roselli, C., Klarin, D., Emdin, C. A., Hilvering, C. R. E., Bianchi, V., Mueller, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.049 · Cited by 450 · see citing works

Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell Disease

Esrick, E. B., Lehmann, L. E., Biffi, A., Achebe, M., Brendel, C., Ciuculescu, M. F., Daley, H., MacKinnon, B., Morris, E., Federico, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029392 · Cited by 449 · see citing works

Reactivation of developmentally silenced globin genes by forced chromatin looping

Deng, W., Rupon, J. W., Krivega, I., Breda, L., Motta, I., Jahn, K. S., Reik, A., Gregory, P. D., Rivella, S., Dean, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.050 · Cited by 443 · see citing works

Cornerstones of CRISPR–Cas in drug discovery and therapy

Fellmann, C., Gowen, B. G., Lin, P., Doudna, J. A., & Corn, J. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 442 · see citing works

A method to predict the impact of regulatory variants from DNA sequence

Lee, D., Gorkin, D. U., Baker, M., Strober, B. J., Asoni, A. L., McCallion, A. S., & Beer, M. (2015) · Nature Genetics · doi:10.1038/ng.3331 · Cited by 417 · see citing works

The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis

Amit, I., Winter, D. R., & Jung, S. (2015) · Nature Immunology · doi:10.1038/ni.3325 · Cited by 406 · see citing works

The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers

Amos, C. I., Dennis, J., Wang, Z., Byun, J., Schumacher, F. R., Gayther, S. A., Casey, G., Hunter, D. J., Sellers, T. A., Gruber, S. B., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0106 · Cited by 337 · see citing works

Characterization of Genomic Deletion Efficiency Mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas9 Nuclease System in Mammalian Cells*

Canver, M. C., Bauer, D. E., Dass, A., Yien, Y. Y., Chung, J., Masuda, T., Maeda, T., Paw, B. H., & Orkin, S. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.564625 · Cited by 342 · see citing works

Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits

Ulirsch, J. C., Nandakumar, S. K., Wang, L., Giani, F. C., Zhang, X., Rogov, P., Melnikov, A., McDonel, P., Do, R., Mikkelsen, T. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.048 · Cited by 328 · see citing works

Enhancer biology and enhanceropathies

Smith, E. R., & Shilatifard, A. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2784 · Cited by 310 · see citing works

Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding

Martyn, G. E., Wienert, B., Yang, L., Shah, M., Norton, L. J., Burdach, J., Kurita, R., Nakamura, Y., Pearson, R. C. M., Funnell, A. P. W., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0085-0 · Cited by 300 · see citing works

Models of human core transcriptional regulatory circuitriesPreprint

Saint‐André, V., Alexander Joel Federation, Lin, C. Y., Abraham, B. J., Reddy, J., Lee, T. I., Bradner, J. E., & Young, R. A. (2016) · Genome Research · doi:10.1101/gr.197590.115 · Cited by 290 · see citing works

Therapeutic base editing of human hematopoietic stem cells

Zeng, J., Wu, Y., Ren, C., Bonanno, J., Shen, A. H., Shea, D. N., Gehrke, J. M., Clement, K., Luk, K., Yao, Q., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0790-y · Cited by 277 · see citing works

Anemia: progress in molecular mechanisms and therapies

Sankaran, V. G., & Weiss, M. J. (2015) · Nature Medicine · doi:10.1038/nm.3814 · Cited by 279 · see citing works

Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis

Corvol, H., Blackman, S. M., Boëlle, P., Gallins, P. J., Pace, R. G., Stonebraker, J. R., Accurso, F. J., Clément, A., Collaco, J. M., Dang, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9382 · Cited by 277 · see citing works

Gene therapy using haematopoietic stem and progenitor cells

Ferrari, G., Thrasher, A. J., & Aiuti, A. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-00298-5 · Cited by 256 · see citing works

Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing

Li, K., Liu, Y., Cao, H., Zhang, Y., Gu, Z., Liu, X., Yu, A., Kaphle, P., Dickerson, K. E., Ni, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14362-5 · Cited by 247 · see citing works

Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis

Huang, J., Liu, X., Li, D., Shao, Z., Cao, H., Zhang, Y., Trompouki, E., Bowman, T. V., Zon, L. I., Yuan, G., et al. (2016) · Developmental Cell · doi:10.1016/j.devcel.2015.12.014 · Cited by 239 · see citing works

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Locatelli, F., Lang, P., Wall, D., Meisel, R., Corbacioglu, S., Li, A. M., de la Fuente, J., Shah, A. J., Carpenter, B., Kwiatkowski, J. L., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2309673 · Cited by 253 · see citing works

Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned

Morgan, R. A., Gray, D., Lomova, A., & Kohn, D. B. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.10.010 · Cited by 243 · see citing works

Enhancer variants: evaluating functions in common disease

Corradin, O., & Scacheri, P. C. (2014) · Genome Medicine · doi:10.1186/s13073-014-0085-3 · Cited by 241 · see citing works

The Shh Topological Domain Facilitates the Action of Remote Enhancers by Reducing the Effects of Genomic Distances

Symmons, O., Pan, L., Remeseiro, S., Aktas, T., Klein, F., Huber, W., & Spitz, F. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.10.015 · Cited by 222 · see citing works

Deletions, Inversions, Duplications: Engineering of Structural Variants using CRISPR/Cas in Mice

Kraft, K., Geuer, S., Will, A. J., Chan, W. L., Paliou, C., Borschiwer, M., Harabula, I., Wittler, L., Franke, M., Ibrahim, D. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.016 · Cited by 216 · see citing works

HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers

Stadhouders, R., Aktuna, S., Thongjuea, S., Aghajanirefah, A., Pourfarzad, F., van IJcken, W. F. J., Lenhard, B., Rooks, H., Best, S., Menzel, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71520 · Cited by 210 · see citing works

Molecular basis of β thalassemia and potential therapeutic targets

Thein, S. L. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.06.001 · Cited by 208 · see citing works

Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease

Hoban, M. D., Orkin, S. H., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2015-09-618587 · Cited by 194 · see citing works

Recent Advances in the Treatment of Sickle Cell Disease

Cisneros, G. S., & Thein, S. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00435 · Cited by 204 · see citing works

Haplotype-resolved genome sequencing: experimental methods and applications

Snyder, M. W., Adey, A., Kitzman, J. O., & Shendure, J. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3903 · Cited by 189 · see citing works

Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission

Piel, F. B., Rees, D. C., DeBaun, M. R., Nnodu, O. E., Ranque, B., Thompson, A. A., Ware, R. E., Abboud, M. R., Abraham, A., Ambrose, E. E., et al. (2023) · The Lancet Haematology · doi:10.1016/s2352-3026(23)00096-0 · Cited by 196 · see citing works

Combining SNP-to-gene linking strategies to identify disease genes and assess disease omnigenicity

Gazal, S., Weissbrod, O., Hormozdiari, F., Dey, K. K., Nasser, J., Jagadeesh, K. A., Weiner, D. J., Shi, H., Fulco, C. P., O’Connor, L. J., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01087-y · Cited by 181 · see citing works

CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia

Fu, B., Liao, J., Chen, S., Li, W., Wang, Q., Hu, J., Yang, F., Hsiao, S., Jiang, Y., Wang, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01906-z · Cited by 181 · see citing works

Advances in understanding erythropoiesis: evolving perspectives

Nandakumar, S. K., Ulirsch, J. C., & Sankaran, V. G. (2016) · British Journal of Haematology · doi:10.1111/bjh.13938 · Cited by 173 · see citing works

Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype.

Brendel, C., Guda, S., Renella, R., Bauer, D. E., Canver, M. C., Kim, Y.-J., Heeney, M. M., Klatt, D., Fogel, J., Milsom, M. D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87885 · Cited by 167 · see citing works

Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells

Byrne, S. M., Ortiz, L., Mali, P., Aach, J., & Church, G. M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1246 · Cited by 164 · see citing works

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9

Bauer, D. E., Canver, M. C., & Orkin, S. H. (2014) · Journal of Visualized Experiments · doi:10.3791/52118 · Cited by 158 · see citing works

Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34 + Hematopoietic Stem and Progenitor Cells

Chang, K.-H., Smith, S. E., Sullivan, T., Chen, K., Zhou, Q., West, J. A., Liu, M., Liu, Y., Vieira, B. F., Sun, C., et al. (2017) · Molecular Therapy - Methods &amp; Clinical Development · doi:10.1016/j.omtm.2016.12.009 · Cited by 155 · see citing works

Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells

Grevet, J. D., Lan, X., Hamagami, N., Edwards, C. R., Sankaranarayanan, L., Ji, X., Bhardwaj, S. K., Face, C. J., Posocco, D. F., Abdulmalik, O. Y., et al. (2018) · Science · doi:10.1126/science.aao0932 · Cited by 153 · see citing works

Quantifying on- and off-target genome editing

Hendel, A., Fine, E. J., Bao, G., & Porteus, M. H. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.12.001 · Cited by 152 · see citing works

Anthrax Susceptibility: Human Genetic Polymorphisms Modulating ANTXR2 Expression

Zhang, Z., Zhang, Y., Shi, M., Ye, B., Shen, W., Li, P., Xing, L., Zhang, X., Hou, L., Xu, J., et al. (2015) · Toxins · doi:10.3390/toxins8010001 · Cited by 152 · see citing works

A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?

Cappellini, M. D., Porter, J. B., Viprakasit, V., & Taher, A. T. (2018) · Blood Reviews · doi:10.1016/j.blre.2018.02.001 · Cited by 151 · see citing works

Sickle Cell Anemia and Its Phenotypes

Williams, T. N., & Thein, S. L. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021320 · Cited by 151 · see citing works

Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci

Miller, C. L., Pjanic, M., Wang, T., Nguyen, T., Cohain, A. T., Lee, J. D., Matic, L. P., Hedin, U., Kundu, R. K., Majmudar, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12092 · Cited by 146 · see citing works

Hemoglobin switching’s surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.

Bauer, D. E., & Orkin, S. H. (2015) · Current Opinion in Genetics &amp; Development · doi:10.1016/j.gde.2015.08.001 · Cited by 143 · see citing works

Enhancer Variants Synergistically Drive Dysfunction of a Gene Regulatory Network In Hirschsprung Disease

Chatterjee, S., Kapoor, A., Akiyama, J. A., Auer, D. R., Lee, D., Gabriel, S., Berrios, C., Pennacchio, L. A., & Chakravarti, A. (2016) · Cell · doi:10.1016/j.cell.2016.09.005 · Cited by 135 · see citing works

Current Progress in Therapeutic Gene Editing for Monogenic Diseases

Prakash, V., Moore, M., & Yáñez‐Muñoz, R. J. (2016) · Molecular Therapy · doi:10.1038/mt.2016.5 · Cited by 135 · see citing works

Fetal hemoglobin in sickle cell anemia

Steinberg, M. H. (2020) · Blood · doi:10.1182/blood.2020007645 · Cited by 136 · see citing works

Functional footprinting of regulatory DNA

Vierstra, J., Reik, A., Chang, K.-H., Stehling-Sun, S., Zhou, Y., Hinkley, S. J., Paschon, D. E., Zhang, L., Psatha, N., Bendana, Y. R., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3554 · Cited by 133 · see citing works

Vasculopathy and pulmonary hypertension in sickle cell disease

Potoka, K. P., & Gladwin, M. T. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2014 · Cited by 133 · see citing works

Minireview: Genetic basis of heterogeneity and severity in sickle cell disease

Habara, A. H., & Steinberg, M. H. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216636726 · Cited by 128 · see citing works

Diversifying the structure of zinc finger nucleases for high-precision genome editing

Paschon, D. E., Lussier, S. J., Wangzor, T., Xia, D. F., Li, P. W., Hinkley, S. J., Scarlott, N. A., Lam, S. C., Waite, A. J., Truong, L. N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08867-x · Cited by 128 · see citing works

Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin

Wienert, B., Funnell, A. P. W., Norton, L. J., Pearson, R. C. M., Wilkinson‐White, L. E., Lester, K. L., Vadolas, J., Porteus, M. H., Matthews, J. M., Quinlan, K. G. R., et al. (2015) · Nature Communications · doi:10.1038/ncomms8085 · Cited by 125 · see citing works

Gene Therapy for β-Hemoglobinopathies

Cavazzana, M., Antoniani, C., & Miccio, A. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.024 · Cited by 128 · see citing works

Gene regulatory mechanisms underpinning prostate cancer susceptibility

Whitington, T., Gao, P. H., Song, W., Ross‐Adams, H., Lamb, A. D. G., Yang, Y., Svezia, I., Klevebring, D., Mills, I. G., Karlsson, R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3523 · Cited by 121 · see citing works

miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction

Guda, S., Brendel, C., Renella, R., Du, P., Bauer, D. E., Canver, M. C., Grenier, J. K., Grimson, A., Kamran, S. C., Thornton, J. E., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.113 · Cited by 120 · see citing works

-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies

Rivella, S. (2015) · Haematologica · doi:10.3324/haematol.2014.114827 · Cited by 122 · see citing works

Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype

Luc, S., Huang, J., McEldoon, J. L., Somuncular, E., Li, D., Rhodes, C., Mamoor, S., Hou, S., Xu, J., & Orkin, S. H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.064 · Cited by 125 · see citing works

Emerging genetic therapy for sickle cell disease

Orkin, S. H., & Bauer, D. E. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041817-125507 · Cited by 119 · see citing works

Engineering Delivery Vehicles for Genome Editing

Nelson, C. E., & Gersbach, C. A. (2016) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-080615-034711 · Cited by 118 · see citing works

Gene therapy for sickle cell disease: An update

Demirci, S., Uchida, N., & Tisdale, J. F. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.04.003 · Cited by 119 · see citing works

Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies

Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114 · see citing works

Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies

Wienert, B., Martyn, G. E., Funnell, A. P. W., Quinlan, K. G. R., & Crossley, M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.09.004 · Cited by 115 · see citing works

Genome Editing: A New Approach to Human Therapeutics

Porteus, M. H. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124454 · Cited by 116 · see citing works

CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments

Laurent, M., Geoffroy, M., Pavani, G., & Guiraud, S. (2024) · Cells · doi:10.3390/cells13100800 · Cited by 122 · see citing works

Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis

Sher, F., Hossain, M. A., Seruggia, D., Schoonenberg, V. A. C., Yao, Q., Cifani, P., Dassama, L. M. K., Cole, M. A., Ren, C., Vinjamur, D. S., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0453-4 · Cited by 109 · see citing works

A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression

Gallagher, M. D., Posavi, M., Huang, P., Unger, T. L., Berlyand, Y., Gruenewald, A. L., Chesi, A., Manduchi, E., Wells, A. D., Grant, S. F. A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.004 · Cited by 109 · see citing works

Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies

Lettre, G., & Bauer, D. E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01341-0 · Cited by 104 · see citing works

Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania

Nkya, S. W., Singh, T., Rooks, H., Mgaya, J., Mariki, H., Soka, D., Mmbando, B. P., Msaki, E. B., Kolder, I. C. R. M., Thein, S. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111464 · Cited by 106 · see citing works

Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci

Canver, M. C., Lessard, S., Pinello, L., Wu, Y., Ilboudo, Y., Stern, E. N., Needleman, A. J., Galactéros, F., Brugnara, C., Kutlar, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3793 · Cited by 105 · see citing works

Molecular and cellular mechanisms that regulate human erythropoiesis

Caulier, A., & Sankaran, V. G. (2021) · Blood · doi:10.1182/blood.2021011044 · Cited by 105 · see citing works

Efficient engineering of human and mouse primary cells using peptide-assisted genome editing

Zhang, Z., Baxter, A. E., Ren, D., Qin, K., Chen, Z., Collins, S. M., Huang, H., Komar, C. A., Bailer, P. F., Parker, J. B., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01756-1 · Cited by 105 · see citing works

Enabling functional genomics with genome engineeringPreprint

Hilton, I. B., & Gersbach, C. A. (2015) · Genome Research · doi:10.1101/gr.190124.115 · Cited by 104 · see citing works

Current and future alternative therapies for beta-thalassemia major

Dreuzy, E. D., Bhukhai, K., Leboulch, P., & Payen, E. (2016) · Biomedical Journal · doi:10.1016/j.bj.2015.10.001 · Cited by 101 · see citing works

Predicting the impact of non-coding variants on DNA methylation

Zeng, H., & Gifford, D. K. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx177 · Cited by 98 · see citing works

Identification of non-coding silencer elements and their regulation of gene expression

Pang, B., van Weerd, J. H., Hamoen, F. L., & Snyder, M. P. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00549-9 · Cited by 97 · see citing works

Gene regulatory networks in the immune system

Singh, H., Khan, A. A., & Dinner, A. R. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.03.006 · Cited by 99 · see citing works

Sickle cell disease: Clinical presentation and management of a global health challenge

Houwing, M. E., de Pagter, P. J., van Beers, E. J., Biemond, B. J., Rettenbacher, E., Rijneveld, A. W., Schols, E. M., Philipsen, J. N. J., Tamminga, R. Y. J., van Draat, K. F., et al. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.05.004 · Cited by 101 · see citing works

Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies

Magrin, E., Miccio, A., & Cavazzana, M. (2019) · Blood · doi:10.1182/blood.2019000949 · Cited by 97 · see citing works

A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease

Pule, G. D., Mowla, S., Novitzky, N., Wiysonge, C. S., & Wonkam, A. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2015.1078235 · Cited by 97 · see citing works

Genetic Study of Complex Diseases in the Post-GWAS Era

Huang, Q. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.02.001 · Cited by 97 · see citing works

Gene regulation at a distance: From remote enhancers to 3D regulatory ensembles

Spitz, F. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.06.017 · Cited by 94 · see citing works

Genome-wide compendium and functional assessment of in vivo heart enhancers

Dickel, D. E., Barozzi, I., Zhu, Y., Fukuda, Y., Osterwalder, M., Mannion, B. J., May, D., Spurrell, C. H., Plajzer-Frick, I., Pickle, C. S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12923 · Cited by 94 · see citing works

KLF1 drives the expression of fetal hemoglobin in British HPFH

Wienert, B., Martyn, G. E., Kurita, R., Nakamura, Y., Quinlan, K. G. R., & Crossley, M. (2017) · Blood · doi:10.1182/blood-2017-02-767400 · Cited by 94 · see citing works

Fine-Mapping and Genome Editing Reveal An Essential Erythroid Enhancer At The HbF-Associated BCL11A Locus

Bauer, D. E., Kamran, S. C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M. C., Smith, E. C., Pinello, L., et al. (2013) · Blood · doi:10.1182/blood.v122.21.437.437 · Cited by 1 · see citing works

HbF-Associated Genetic Variation Marks an Erythroid Regulatory Element Essential for BCL11A Transcription and Subsequent Stage-Specific Globin Expression

Bauer, D. E., Kamran, S. C., Xu, J., Lin, C., Shao, Z., Fujiwara, Y., Voit, R. A., Porteus, M. H., Stamatoyannopoulos, J. A., & Orkin, S. H. (2012) · Blood · doi:10.1182/blood.v120.21.828.828

53. From GWAS To the Clinic: Genome-Editing the Human BCL11A Erythroid Enhancer for Fetal Globin Elevation in the Hemoglobinopathies

Reik, A., Chang, K.-H., Vierstra, J. D., Psatha, N., Stehling-Sun, S., Zhou, Y., O’Neil, C. M., Mich, A., Miller, J. C., Lee, G., et al. (2015) · Molecular Therapy · doi:10.1016/s1525-0016(16)33658-9 · Cited by 2 · see citing works

Recent advances in globin research using genome‐wide association studies and gene editing

Orkin, S. H. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13001 · Cited by 17 · see citing works

Post GWAS functional characterization of BCL11A locus toward the development of a treatment for B-thalassemia

(2013) · P-arch (Science and Technology Park of Sardinia)